MedPath

Oxybutynin Chloride

OXYBUTYNIN CHLORIDE TABLETS USP

Approved
Approval ID

246d2f79-8ab5-4023-9068-1451b695ac16

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 19, 2020

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxybutynin Chloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71335-0519
Application NumberANDA071655
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxybutynin Chloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 20, 2019
FDA Product Classification

INGREDIENTS (7)

CALCIUM STEARATEInactive
Code: 776XM7047L
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
OXYBUTYNIN CHLORIDEActive
Quantity: 5 mg in 1 1
Code: L9F3D9RENQ
Classification: ACTIB
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
ALUMINUM OXIDEInactive
Code: LMI26O6933
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxybutynin Chloride - FDA Drug Approval Details